← The Wire
XERSNasdaq
Xeris Biopharma Holdings, Inc.
Pharmaceutical Preparations · CIK 1867096
Develops and commercializes therapies for chronic endocrine and neurological diseases using proprietary formulation technology
red 8-K · 90d
$1.17B
Market cap
$7.74
Last close
+0.7%
1D
+12.2%
5D
2.6M
Volume
Price · last 39 sessions+22.1%
May 4L $5.89 · H $7.74Jun 29
90
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GJan 26, 2024SC 13GSC 13GFeb 10, 2023SC 13GSC 13GJan 14, 2022SC 13GSC 13GJan 5, 2022
Insider Activity
In the 90 days to Mar 2, 2026: 5 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Hecht BethSee Remarks | Sell | 16,567 | $6.24 | $103K |
| Mar 2, 2026 | Hecht BethSee Remarks | Sell | 100 | $7.06 | $706 |
| Feb 2, 2026 | Hecht BethSee Remarks | Sell | 16,667 | $7.45 | $124K |
| Jan 8, 2026 | Mcculloch KevinSee Remarks | Sell | 15,000 | $8.00 | $120K |
| Jan 5, 2026 | Shannon John Patrick JrSee Remarks | Sell | 24,907 | $7.08 | $176K |
| Jan 2, 2026 | Hecht BethSee Remarks | Sell | 16,667 | $7.43 | $124K |
| Dec 19, 2025 | Johnson JohnDirector | Sell | 135,400 | $7.22 | $978K |
| Dec 12, 2025 | Bormann-Kennedy Barbara-Jean AnneDirector | Sell | 15,000 | $7.09 | $106K |
| Dec 1, 2025 | Hecht BethSee Remarks | Sell | 16,667 | $7.01 | $117K |
| Nov 13, 2025 | Shannon John Patrick JrSee Remarks | Sell | 23,242 | $7.46 | $173K |
| Nov 11, 2025 | Hecht BethSee Remarks | Sell | 16,667 | $7.40 | $123K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance